Abstract
Objective
This study explores the factors influencing death anxiety in patients with advanced cancer, and to investigate the role of family function on death anxiety, and the correlation between meaning in life and death anxiety.
Methods
Patients with advanced cancer who were hospitalized in three institutions from November 2020 to May 2021 were recruited in this cross-sectional study. The Chinese version of the Death and Dying Distress Scale, Meaning in Life Scale For Advanced Cancer Patients and Family APGAR Index were used to assess death anxiety, meaning in life and family function. Pain symptoms were evaluated by the Numeric Rating Scale. Karnofsky Performance Status, patients’ socio-demographic and clinical variables were also recorded. Statistical analyses were performed using IBM SPSS Statistics for Windows (version 26.0). Multivariate regression analysis was performed to examine the correlations of social-demographic and clinical variables with family function and death anxiety.
Results
Three hundred and twenty-eight patients with advanced cancer were included in this study. The results showed that 12.2% of patients experienced moderate to severe death anxiety. Meaning in Life Scale For Advanced Cancer Patients (acceptance of death, controlling one's life), types of institution (oncology department of tertiary hospitals), self-perceived economic burden (extreme), Karnofsky Performance Status score, age, and medical insurance status (self-paid, inter-provincial medical insurance) were identified as associated factors of death anxiety (R2 = 0.335, F = 20.072, P < 0.001). Patients with good family function scores had significantly low level of death anxiety in univariate analysis (F = 5.892, P = 0.003). Multivariate analysis revealed no significant association between family function and death anxiety.
Conclusions
Our results demonstrated that the oncology department of a tertiary hospital, extremely high of self-perceived economic burden, self-pay, and inter-provincial medical insurance might be associated with higher death anxiety in patients with advanced cancer. Lower level death anxiety was associated with higher level acceptance of death, a greater sense of life control, better physical performance, and older age. Further confirmation about the association between family function and death anxiety in patients with advanced cancer is warranted in the future.
Keywords: Death anxiety, Meaning in life, Family function, Advanced cancer
Introduction
Cancer has become a serious global major health issue globally. The International Agency for Research on Cancer reported that about 19.29 million new cancer cases and 9.96 million cancer-related deaths worldwide in 2020.1 Approximate number of 4.57 million new cancer cases and 3 million deaths were confirmed from China, accounting for 23.7% and 30.1% globally.2 Most patients with cancer were diagnosed at the middle or advanced stages, forfeiting the best treatment opportunity.3,4 Patients with terminal cancer were psychologically threatened by death and bear a huge burden of disease.5,6
Death anxiety is a conscious or unconscious state of mind in humans to activate defense mechanisms when facing the threat of death7,8 and is the basis or a strong explanation for many mental disorders.9,10 Studies have shown that patients with advanced cancer commonly experience death anxiety7,11, 12, 13, 14 and may even develop intensified death anxiety. One study revealed that more than 43% of patients with advanced cancer suffered from moderate to severe death anxiety.14
Death anxiety has been reported to be negatively correlated with life satisfaction,15 reducing quality of life,16 causing distress to families,16 and seriously affecting physical and mental health, as well as the prognosis of patients with cancer.17 Additionally, it can become a barrier to advance care planning and end-of-life preparation.18 The presence of death anxiety may lead to a desire to hasten death.19 If left unaddressed, euthanasia or physician-assisted suicide may be performed.20 Death anxiety has been listed as a nursing diagnosis by The official North American Nursing Diagnosis Association International,21 and relief of death anxiety is deemed to be a necessity of caring for terminally ill patients in palliative care.12,22
Previous research findings indicated that cultural, socio-demographic factors, and clinical characteristics influence the level of death anxiety.23, 24, 25, 26 Moreover, cancer type,23 VAS score,27 having children under 18,7 burden of pain,7 and gender28 were shown to be associated with death anxiety in patients with advanced cancer. Meaning in life appears to be significantly correlated with death anxiety in older adults and patients with cancer.29, 30, 31 Meaning in Life is considered when an individual feels guided by valuable goals and feels valuable in life.32 Family support, such as providing emotional communication, social support, and helping in dealing with stressful life events, is the primary source of meaning in life.11,23,33, 34, 35 Establishing and maintaining close relationships with significant family members and friends could be beneficial for individuals to cope with the fear of death.36 Although family function and meaning in life significantly affect patients with advanced cancer, the relationship between family function and death anxiety in these terminally ill patients has not yet been reported.
Due to the uniqueness of Chinese cultural attitudes and beliefs toward death,1,37 research on death anxiety and its associated factors in Chinese patients with advanced cancer may greatly advance cross-cultural knowledge in this field. However, there is a very minute quantity of studies that directly examine Chinese patients with advanced cancer attitudes toward death. One study38 reported that the death anxiety of patients with advanced cancer was associated with adult children, low daily activities, and aggressive coping mode (resignation and confrontation). One death anxiety evaluation tool, 5-point Likert-type Chinese Version of Templer-Death Anxiety Scale (CL-TDAS), was not specifically developed to assess advanced cancer due to some non-cancer-specific items, and patients’ psychological and physiological changes were ignored.39 The Chinese version of the Death and Dying Distress Scale (DADDS-C) was used in this study to evaluate death anxiety in patients with advanced cancer. The psychological characteristics and sensitivity of death anxiety-related factors have been extensively validated by DADDS-C.12,40 Thus, this study aimed to fulfill the knowledge gap by exploring the relationship between death anxiety and certain psychosocial variables of Chinese patients with advanced cancer. Furthermore, the relationship between family function, meaning in life, and death anxiety in these patients were investigated.
Methods
Participants and procedures
We conducted a cross-sectional investigation of death anxiety in patients with advanced cancer who were hospitalized in three medical institutions. The sample size was calculated using the Kendall method,41 which stated that the sample size estimates for multivariate linear regression could be 10 to 20 times the number of variables number. With about 20 independent variables in this study, and given that 20% of the questionnaires were invalid, at least 240 {(1 + 20%)∗ 10∗ 20} patients were needed in this study.
We recruited participants voluntarily by convenience sampling from November 2020 to May 2021. Participants were recruited over a 4-month period in the oncology department of a tertiary general hospital and a secondary general hospital in Shantou, and over a 3-month period in a tumor center of a tertiary hospital in Zhuhai, China. Patients were enrolled if they were aged 18 or older, diagnosed with stage III or IV cancer, able to read and write Chinese. Patients who refused to participate in the study, had cognitive impairment and were in a critical condition were excluded from this survey.
A research nurse, who described the study purpose, contents, and potential benefits/risks of the study to all participants in the same way, collected all questionnaires. After informed consent was obtained, participants were invited to complete the questionnaires by themselves. When a patient could not complete the questionnaire, the research nurse read the items verbally and recorded the patient's responses. All questionnaires was returned to the researchers on the spot after the participants completed it. The average time for completing the questionnaire was 28.4 ± 11.3 (21–43) min.
This study was approved by the Ethics Committee of the First Affiliated Hospital of Shantou University Medical College (Approval No. 20190112).
Measures
Socio-demographic and clinical characteristics
The following demographic and clinical data were obtained from participants at recruitment and were also extracted from the medical record: age, gender, marital status, education level, employment status, medical insurance status, religion, caregiver employment status, types of institution, self-perceived economic burden, having children under 18 of age, unmarried children, time since confirmed diagnosis, types of cancer, and Numeric Rating Score (NRS)42 that was most widely used as a single dimension pain assessment scale. The patients were allowed to mark their pain scores varying from 0–10 (0 indicated painless, 1–3 mild pain, 4–6 moderate pain, and 7–10 severe pain). Performance status was defined using Karnofsky Performance Status (KPS) score,43 which was an eleven point scale suggesting the correlation with the percentage score ranging from 0 to 100 (indicating normal, no signs, or symptoms to death). The higher score signified less physical impairment.
Family APGAR index44
Family APGAR Index was a measurement to explore the patient's satisfaction with family function (FA), which included five parameters: adaptation, partnership, growth, affection, and resolve. This index was introduced in 1978 and validated for the Chinese population in 1995. The responses of each dimension (item) related to ‘almost always’, ‘some of the time’ and ‘hardly ever’, were scored as 2 points, 1 point, and 0 points, respectively. Thus, these scores ranged from 0 to 10 representing low to high satisfaction with family function: 7–10 indicating good family function; 4–6 indicating moderate family dysfunction; 0–3 indicating severe family dysfunction. The test-retest reliability of the questionnaire was 0.80–0.83. The Chinese version of APGAR has been widely applied in China with excellent validity and reliability.45 In this study, Cronbach's α of this scale was 0.83.
Meaning in life scale for advanced cancer patients46
Meaning in life scale for advanced cancer patients (MiLS) was used to assess meaning in life, which was a self-report questionnaire consisting of 28 items, with each question answered on a five-point scale. All items were classified into 6 dimensions31: meaning and satisfaction in life (the extent to which an individual had a clear, strong, and meaningful life purpose and was satisfied with his/her life purpose), control of life (the extent to which an individual was free to make life choices and was responsible for his/her life), will to seek meaning (the motivation of an individual to seek meaning for self-existence), bearing suffering (the extent to which an individual understood the meaning of suffering and accepted it), existential frustration (the extent to which an individual suffered from existential frustration caused by the lack of meaning or purpose and the feeling of emptiness and anxiety), and acceptance of death (the extent to which an individual was not afraid of death). MiLS was testified to have good internal consistency in Chinese patients with advanced cancer (Cronbach's α = 0.725, 0.577–0.736 for each dimension).46 Higher score indicated having a greater meaning in life. In this research, Cronbach's α of MiLS was 0.772.
DADDS-C
DADDS-C was used to measure death anxiety. DADDS that was developed to evaluate individuals with advanced or metastatic cancer, broadly captured distress about the loss of time and opportunity, the process of death, and dying and their impact on others.12 A total of 15 items were used to assess death anxiety, with each item corresponding to the options on a 6-point Likert scale ranging from 0 (no distress) to 5 (extreme distress). Total DADDS scores varied from 0 to 75, with higher scores indicating more significant death anxiety. Chen et al40 formulated the Chinese Version Scale (DADDS-C) in 2016 with the CVI value of each item on the scale being between 0.875 and 1.000. The overall Cronbach's α coefficient was 0.960, proving that it could be used to evaluate the death anxiety of patients with advanced cancer in China. In this study, Cronbach's α coefficient on the scale was 0.909. We also used 45 points to identify individuals with at least a moderate level of death anxiety, as this value was rated as ‘3’ (experiencing moderate distress) across 15 items of the scale.7,47
Data analysis
Statistical analyses were performed using IBM SPSS Statistics for Windows, version 26.0 (IBM Corp., Armonk, N.Y., USA).48 All significant tests were two-tailed with a significance level of P < 0.05. Descriptive statistics including means, standard deviations, and frequencies were calculated for demographic and clinical variables including MiLS score, the total score of DADDS-C as well as each item. Independent T-tests and one-way ANOVA were performed to compare continuous dependent variables (total DADDS-C score) to show the differences in family function, socio-demographic, and clinical variables.
The associations between the MiLS, Age, KPS score, NRS score, and DADDS-C were explored by using Spearman rank correlation.
Multiple linear regression adjusted for confounders were performed to examine the correlation between social-demographic and clinical variables, MilS, family function, and death anxiety. To identify the significant factors associated with total DADDS-C score, variables with a P < 0.20 in the univariate analysis were included in multivariate linear stepwise regression models, with all of classification variables being changed to dummy variables.49
Results
Participants’ characteristics
A total of 362 patients with advanced cancer were surveyed, and 328 valid questionnaires were recovered, yielding a 90.61 percent effective recovery rate. Patients’ age was 56.6 ± 12.3 years (range 21–85 years), and the time since diagnosis was 25.5 ± 30.7 months (range 1–187 months). The KPS score was 69.6 ± 17.1 points (range 10–100 points), and the NRS score was 0.6 ± 1.1 points (range 0–7 points). Other detailed socio-demographic and clinical characteristics of the participants are presented in Table 1 and Table 2.
Table 1.
Socio-demographic and the associations with the DADDS-C in patients with advanced cancer (n = 328).
| Variables | n (%) | Mean score | SD score | Significant |
|---|---|---|---|---|
| Gender | ||||
| Male | 183 (55.8) | 24.46 | 16.08 | 0.423∗ |
| Female | 145 (44.2) | 25.83 | 14.34 | |
| Marital status | ||||
| Unmarried/Widowed/Divorced | 49 (14.9) | 23.63 | 14.99 | 0.479∗ |
| Married | 279 (85.1) | 25.32 | 15.40 | |
| Education Level | ||||
| Primary school and below/Junior high school | 183 (55.8) | 25.47 | 14.77 | 0.591∗ |
| High school/Secondary technical school/College or higher | 145 (44.2) | 24.55 | 16.04 | |
| Religion | ||||
| No | 161 (49.1) | 23.47 | 15.33 | 0.067∗ |
| Yes | 167 (50.9) | 26.55 | 15.06 | |
| Employment status | ||||
| Employed | 99 (30.2) | 25.33 | 15.75 | 0.818∗ |
| Unemployed/retired | 229 (69.8) | 24.91 | 15.06 | |
| Primary caregiver | ||||
| Spouse | 162 (49.4) | 26.26 | 15.36 | 0.209∗∗ |
| Child/children | 88 (26.8) | 25.00 | 15.48 | |
| Others | 78 (23.8) | 22.54 | 14.64 | |
| Primary caregiver Employment status | ||||
| Employed | 160 (48.8) | 25.41 | 16.13 | 0.663∗ |
| Unemployed/retired | 168 (51.2) | 24.68 | 14.40 | |
| Whether having children under 18 of age | ||||
| No | 264 (80.5) | 24.45 | 14.48 | 0.208∗ |
| Yes | 64 (19.5) | 27.58 | 18.34 | |
| Unmarried children | ||||
| No | 163 (49.7) | 22.54 | 14.00 | 0.003∗ |
| Yes | 165 (50.3) | 27.56 | 16.19 | |
| Self-perceived economic burden | ||||
| Extreme | 105 (32.0) | 29.98 | 16.09 | <0.001∗∗ |
| Severe | 78 (23.8) | 25.56 | 13.68 | |
| Moderate | 99 (30.2) | 21.81 | 14.72 | |
| Mild | 31 (9.4) | 20.77 | 14.70 | |
| None at all | 15 (4.6) | 18.40 | 14.36 | |
SD: Standard deviation.
Independent t-tests.
One-way ANOVA.
Table 2.
Clinical status, family function, and the associations with the DADDS-C in patients with advanced cancer (n = 328).
| Variables | n (%) | Mean score | SD score | Significant |
|---|---|---|---|---|
| Types of Institution | ||||
| Oncology Section of Secondary Hospital | 75 (22.9) | 25.20 | 15.26 | <0.001∗∗ |
| Oncology Department of Tertiary Hospitals | 82 (25.0) | 30.57 | 13.82 | |
| Tumor Center of Tertiary Hospital | 171 (52.1) | 22.36 | 15.41 | |
| Medical insurance status | ||||
| Municipal Health Insurance | 232 (70.7) | 24.63 | 15.59 | 0.123∗∗ |
| Provincial Medical Insurance | 53 (16.2) | 24.53 | 14.52 | |
| Inter-Provincial Medical Insurance | 29 (8.8) | 24.07 | 11.86 | |
| Institutional Payment/Free | 3 (0.9) | 37.04 | 26.28 | |
| Self-paid | 11 (3.4) | 35.36 | 13.86 | |
| Types of cancer | ||||
| Nasopharynx | 17 (5.2) | 18.89 | 15.48 | 0.219∗∗ |
| Esophagus | 11 (3.4) | 23.55 | 17.65 | |
| Stomach | 25 (7.6) | 25.88 | 14.84 | |
| Lung | 64 (19.5) | 27.64 | 15.82 | |
| Breast | 44 (13.4) | 27.25 | 13.43 | |
| Liver | 11 (3.4) | 32.91 | 14.44 | |
| Colon/rectum | 89 (27.0) | 23.48 | 14.99 | |
| Gynecological | 21 (6.4) | 24.05 | 13.72 | |
| Lymphoma | 14 (4.3) | 19.00 | 13.77 | |
| Others | 32 (9.8) | 24.82 | 17.46 | |
| Time since confirmed diagnosis (months) | ||||
| <12 | 161 (49.1) | 25.48 ± 15.69 | 0.124 | 0.883∗∗ |
| 12–36 | 89 (27.1) | 24.54 ± 16.23 | ||
| >36 | 78 (23.8) | 24.79 ± 13.57 | ||
| Family function (FA) | ||||
| Severe family dysfunction | 12 (3.7) | 27.50 | 23.91 | 0.003∗∗ |
| Moderate family dysfunction | 47 (14.3) | 31.85 | 14.14 | |
| Good family function | 269 (82.0) | 23.77 | 14.79 | |
SD: Standard deviation.
Tumor center of tertiary hospital is distinguished by the presence of multiple oncology departments, which can be classified as head and neck oncology, thoracic oncology, and so on. Each department has its own bed and treats patients with specific conditions, such as nasopharyngeal cancer of the head and neck. In a word, the tertiary hospital's tumor center, is made up of several oncology departments. Tumor center of tertiary hospital in this study has more than 300 beds.
Oncology department of tertiary hospitals does not categorize the tumor types, and has a small number of beds. Oncology department of tertiary hospitals in this study have fewer than 40 beds.
Others in ‘Types of cancer’ including Pancreas, Prostate, Kidney, Bladder, Mandible, Neck, Pleural, Thymus, Gallbladder, Ampullary, Testicle, Peritoneum, Ewing sarcomas, Synoviosarcoma, Osteosarcoma, and undefined.
One-way ANOVA
Death anxiety
The total death anxiety score was 25.1 ± 15.3 points (range 0–71). A total of 40 (12.2%) of the patients presented with moderate to severe death anxiety (scores ≥ 45). Fig. 1 shows the frequency of patients reporting each item (scores ≥ 3 indicating at least moderate distress). The most frequent concerns were as follows: being a burden to others (68.9%), the impact of death on loved ones (59.5%), and not having a future (42.4%). Notably, even the least frequent concern (distress being prolonged or drawn out) was reported by 14.3% of participants.
Fig. 1.
Frequency of patients reporting each item (cut-off ≥ 3 indicating at least moderate distress) of DADDS-C (n = 328) Fig. 1. Frequency of each item (n = 328). Moderate distress is defined by item ratings ≥ 3. The question stem for items 1 to 10 was ‘Over the past 2weeks, how distressed did you feel about … ’. And The question stem for items 11 to 15 was over the past 2weeks, how distressed did you feel when thinking about your death may.
Perceived sense of meaning in life
The total MiLS score was 107.77 ± 12.95 points (range 70–136). The score of 6 dimensions are presented in Table 3.
Table 3.
Mean scores on the MiLS.
| Variables | Mean score | SD score | Range |
|---|---|---|---|
| Will to seek meaning | 15.48 | 3.20 | 7–20 |
| Existential frustration | 19.42 | 3.31 | 8–25 |
| Meaning and satisfaction in life | 14.47 | 3.03 | 7–20 |
| Controlling one's life | 28.70 | 4.05 | 8–35 |
| Bear suffering | 14.69 | 3.35 | 4–20 |
| Acceptance of death | 15.10 | 2.83 | 5–20 |
Univariate analysis
The analysis of the variables associated with DADDS-C indicated that patients having unmarried children (P = 0.003), bearing self-perceived economic burden (extremely high) (P < 0.001), hospitalized in certain institution (oncology department of tertiary hospitals) (P < 0.001), and had moderate family dysfunction (P < 0.003) experienced a high level of death anxiety (Table 1 and Table 2). Death anxiety was significantly associated with age, KPS score, NRS score, and MiLS (total score and the scores of five dimensions except for “will seek meaning”). NRS score was positively correlated with death anxiety (r = 0.133), and other variables were negatively correlated with death anxiety (r = -0.112∼-0.251) (Table 4).
Table 4.
Correlations of DADDS-C with age, MiLS (total score, each dimension), NRS score, and KPS score.
| Variable | Death anxiety | |
|---|---|---|
| Age | −0.112∗ | |
| KPS score | −0.218∗∗ | |
| NRS score | 0.133∗ | |
| MiLS | Total score | −0.251∗∗ |
| Will to seek meaning | 0.002 | |
| Existential frustration | −0.211∗∗ | |
| Meaning and satisfaction in life | −0.194∗∗ | |
| Controlling one's life | −0.238∗∗ | |
| Bear suffering | −0.116∗ | |
| Acceptance of death | −0.360∗∗ | |
∗∗P<0.001; ∗P< 0.05, Will to seek meaning: P = 0.974.
Multiple linear regression analysis
Multivariate regression analysis suggested that death anxiety was positively correlated with institution type (oncology department of tertiary hospitals), self-perceived economic burden (extremely high), and medical insurance status (inter-provincial medical insurance and self-paid). Death anxiety was negatively correlated with MiLS (acceptance of death and controlling life), KPS score, and age (Table 5).
Table 5.
Regression of death anxiety on key explanatory factors (n = 328).
| Variable | B | Beta | t | P | 95%CI |
|---|---|---|---|---|---|
| Constant | 86.342 | – | 11.646 | <0.001 | 71.756–100.927 |
| MiLS (Acceptance of death) | −2.032 | −0.374 | −8.038 | <0.001 | −2.529∼-17.368 |
| Types of institution (Oncology Department of Tertiary Hospitals) | 8.894 | 0.252 | 5.326 | <0.001 | 5.608–12.179 |
| Self-perceived economic burden (Extreme) | 6.388 | 0.195 | 4.142 | <0.001 | 3.354–9.423 |
| KPS score | −0.192 | −0.214 | −4.196 | <0.001 | −0.282∼-0.102 |
| Age | −0.202 | −0.163 | −3.301 | 0.001 | −0.323∼-0.082 |
| Medical insurance status (Inter-Provincial Medical Insurance) | 6.66 | 0.124 | 2.572 | 0.011 | 1.566–11.754 |
| Medical insurance status (Self-paid) | 9.048 | 0.106 | 2.302 | 0.022 | 1.314–16.783 |
| MiLS (Controlling one's life) | −0.382 | −0.101 | −2.047 | 0.041 | −0.750∼-0.015 |
Independent variables: DADDS-C score.
R = 0.579, R2 = 0.335, adjust R2 = 0.318, F = 20.072, P<0.001.
“-”indicates that the data does not exist.
Discussion
In this study, we found that death anxiety in patient with advanced cancer were associated with MiLS, institution, self-perceived economic burden, KPS score, age, and medical insurance status. Contrary to previous studies, we did not find any correlation between having children under 18 years7 and death anxiety. Patients with higher family function scores had significantly lower death anxiety in univariate analysis, but it turned out that family function was not the associated factors of death anxiety based on multivariate analysis.
In this study, 40 (12.2%) patients with advanced cancer reported moderate to severe death anxiety based on a cut-off score of 45 on DADDS-C, which was lower than the results from previous studies (27.4%–45%).7,12,14,47 The most and the least distressing items identified in our study were inconsistent with previous findings.7,47 Examination results revealed that the percentage of patients suffering moderate to extreme distresses was calculated based on a cut-off score of 3 on each item of DADDS-C, which classifying moderate to extremely distress on 2 of 15 items. The item rated as most distressing on DADDS-C was ‘asked about being a burden to others’, which suggested that death anxiety was significantly associated with patients' perceived meaning in life (his/her importance to others) and close relationship with family members. The DADDS-C items rated as minimum distress with concerning fear along with the thought of death and dying may be prolonged or drawn out. The low level of distress about the thought of death ‘be prolonged or drawn out’ and ‘not having said all the things I want to say to the people I care about’ might indicate the presence of less consciousness to death or non-acceptance of forthcoming mortality, or meaningful medical care and family support for most individuals participating this study.
Perceived meaning in life was negatively correlated with death anxiety, so meaning in life might be a protective factor against death anxiety. This finding was consistent with previous results and Terror Management Theory.29,50 The novelty of this finding lied in the main construction of explanation factors. First, the dimension of ‘acceptance of death’ was the extent to which an individual was not afraid of death, the dimension ‘control of life’ was the extent to which an individual was free to make life choices and was responsible for his/her life. Both ‘acceptance of death’ and ‘control of life’ were identified to be the primary protective factors against death anxiety in this study, which indicated that people with lower death anxiety were not afraid/denied of death and could plan for their own death. Unlike Terror Management Theory, people deny death and tend to obtain meaning through a set of cultural worldviews and beliefs, which may promote a sense of symbolic immortality against the fear of death. Second, the dimension ‘will to seek meaning’ (the motivation of an individual to seek meaning and a purpose for self-existence) was not the associated factor of death anxiety, which was inconsistent with the finding that searching for meaning in life was negatively correlated with death anxiety of Chinese college students and the elderly.30,51 Thus, the specificity of this population may be highlighted in future research into meaning in life, death anxiety, and the relationship between them.
The institution where patient was hospitalized was correlated with death anxiety, with the highest level of death anxiety among hospitalized patients in the oncology department of tertiary hospitals. Notably, patients' hospitalization costs in tertiary general hospitals may be generally higher than those in secondary general hospitals.52 Besides, in comparison with the cancer center of tertiary hospital, the beds in the oncology department of tertiary hospitals are more crowded, and the relevant specialties are not clearly divided, which will complicate the treatment, nursing, and education of specialized diseases, and the patients are more concerned about the tumors. Thus, it is necessary to carry out tumor-related knowledge education, and comprehensively coordinate the diagnosis and treatment resources of different types/levels of medical institutions, so that patients can obtain a better experience in consultation and treatment, help reducing patients' anxiety about death.
Self-perceived economic burden (extremely high) was strongly associated with death anxiety in patients with advanced cancer. According to a National Cancer Center survey, the annual per capita medical expenses for patients with malignant tumor ($9739) far outweigh their families' average annual income ($8607).53 Cancer treatment really brings a huge economic pressure for individuals and their families. Aside from the symptom burden imposed by the disease itself,54 side effects associated with anti-tumor therapy or maintenance therapy add to patients' economic, physical, and mental burdens. Studies have shown that nearly one-quarter of patients experience moderate to severe depression and low morale,55,56 as well as suicidal ideation/desire to hasten death.55,57 Depression, low morale, and the desire to hasten death are associated with death anxiety.14,58,59 As a result, the participating institutions need to pay more attention to the financial support of patients with advanced cancer and give them more economic help to reduce the negative impact of self-perceived economic burden and to promote the adjustment of patients themselves.
Performance status was negatively correlated with death anxiety in this study. We found that patients with low KPS scores might have greater anxiety than those with higher KPS scores. The patient with a lower KPS score would have more physical dysfunction, increasing actual dependency on others and additional self-perceived burden they may face.4,60 To call a nurse or family members frequently for help such as eating, disposing of urine and stools, and so on may lead them to feel meaningless of life, loss of dignity, even desire for hastened death.61, 62, 63 Thus, in clinical practice, attention should be paid to the assessment of the physical state and activity of patients with advanced cancer in order to take appropriate measures to improve self-care ability, prevent and reduce the production of related negative emotions.
There remained a negative association between death anxiety and age, consistent with the life-stage perspective and the previous research findings.64,65 Older individuals may have more capacity to manage a traumatic event and more frequent contemplation of death. Instead, younger patients may face the issue of child dependence. Some of the children are minors, and they will consider the support of their children if they die. The negative effects of lacking parental companionship in the process of growing up, and being more concerned about their children's future, will lead to an increased level of death anxiety.7 As a result, future clinical staff should pay more attention to the death anxiety level of younger patients with advanced cancer.
Otherwise, medical insurance status (self-paid, and inter-provincial medical insurance) were positively correlated with death anxiety. Dealing with cancer is a significant financial stress for individuals, their families, and the community is enormous but has micro effects on disease. ‘Poverty reinstatement due to illness’ and ‘poverty due to illness’ were not rare in China and was known by the patient and their family members. ‘Self-paid’ indicates that all the cost of treatment is paid, which is undoubtedly a great burden. As for inter-provincial medical insurance, it might reflect the phenomenon of remote medical treatment such as66: (1) ineligible for instant reimbursement; (2) decreasing reimbursement rate; (3) increasing of expense incurred for living; (4) narrowed reimbursement list, and so on, which may significantly increase direct and indirect economic burdens for them, bring a lot of inconveniences. Thus, participating departments may improve the disease-related insurance system for patients with advanced cancer, mediating reimbursement. Medical insurance status (self-paid and inter-provincial medical insurance) should be paid more attention by medical staff to promote the smooth flow of medical treatment and settlement, reducing patients' pressure.
Family function was not found to be associated with death anxiety in multivariate linear analysis. This finding was contrary to expectation but might be explained by sample size-related differences in family function. The frequency of patients with good family function in this study was 82%, those patients with moderate to severe family dysfunction was only 18%. Thus, exploring the relationship between family function and death anxiety may be less sensitive and representative. Family function directly reflects the degree of support provided by the family to individual, the intimacy between family members, and the ability to solve problems together and coping with stress.44 It is closely related to the patient's health status and can assist patients in maintaining psychological, social, and mental health. Patients suffering from family dysfunction may lack emotional connection and effective communication with family members, resulting in unneeded, ununderstood, unappreciated, serious self-burden, meaningless life, falling into a state of self-isolation, and finally choosing to avoid addressing all issues.67 When the disease progresses, the burden of physical symptoms increases and body function declines. There is severe emotional distress, which eventually leads to death anxiety. Nevertheless, future research to clarify the nature of family function that is correlated with death anxiety and the influence of different family functions on the level of death anxiety is needed.
Limitations of this study were as follows: first, our study failed to make any causal inference as it was a cross-sectional study. Second, our findings were indicative but it should be interpreted with caution, as it might only apply to patients with advanced cancer in the neighborhood area. Third, for exploring associated factors of death anxiety, some variables may be less sensitive and representative due to convenience sampling method rather than purpose sampling method. At the same time, literature review suggested that physical symptoms, self-esteem, attachment security,7 attachment avoidance,68 anxiety, depression, and demoralization14,58,68 were correlated with death anxiety. Finally, we did not involve and analyze the interaction or the intermediary role between various factors, which need to be further explored in future studies.
Conclusions
In conclusion, first, patients’ age, performance status, perceived meaning in life, self-perceived economic burden, medical insurance status, and types of institution were important factors associated with death anxiety. Among them, self-perceived economic burden (extremely high), medical expense support (self-pay and inter-provincial medical insurance), and participating institution (oncology department of tertiary hospital) might be associated with higher death anxiety in patients with advanced cancer. Lower levels of death anxiety in patients were associated with higher levels of meaning in life (higher acceptance of death, and greater sense of life control), older age, and better physical performance. Second, the association between family functions with death anxiety may need to be further examined. Finally, based on the findings of our study, we suggested to guide patients with advanced cancer to view the changes in physical function and the economic pressure caused by treatment from multiple perspectives, and accept the inevitability of death, which may help to relieve death anxiety. Moreover, further research on specific interventions and their effects is warranted.
Author contributions
Conceived and designed the analysis: Hui Liu, Wenjuan Ying, Xiaocheng Liu, Zhili Liu, Yanchun Wu. Collected the data: Hui Liu. Contributed data or analysis tools:Hui Liu, Ruihua Zheng, Rongzhi Xie, Hongmei Tao, Xiaocheng Liu. Performed the analysis: Hui Liu, Yao Wang, Zhili Liu, Xiaomin Li. Wrote the paper: Hui Liu, Xiaoying Wu, Ruiling Feng, Yao Wang.
Declaration of competing interest
None declared.
Funding
This study was funded by the Li Ka Shing Foundation Cross-Disciplinary Research Grant (Grant No. 2020LKSFG10B), and the Chinese Nursing Association of 2019 research project (Grant No. ZHKY201927).
Ethics statement
This study was approved by the Ethics Committee of the First Affiliated Hospital of Shantou University Medical College (Approval No. 20190112).
Contributor Information
Wenjuan Ying, Email: Yingwenjuan@126.com.
Xiaoying Wu, Email: 627725932@qq.com.
References
- 1.Sung H., Ferlay J., Siegel R.L., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660. [DOI] [PubMed] [Google Scholar]
- 2.Sleeman K.E., de Brito M., Etkind S., et al. The escalating global burden of serious health-related suffering: projections to 2060 by world region s, age groups, and health conditions. Lancet Global Health. 2019;7(7):e883–e892. doi: 10.1016/S2214-109X(19)30172-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Xiao Yuxue L.J.S.Y. Research progress on evaluation tools of palliative care quality for advanced cancer patients. Chin Nurs Res. 2021;35(3):462–464. [Google Scholar]
- 4.Akazawa T., Akechi T., Morita T., et al. Self-perceived burden in terminally ill cancer patients: a categorization of care strategies based on bereaved family members' perspectives. J Pain Symptom Manag. 2010;40(2):224–234. doi: 10.1016/j.jpainsymman.2009.12.015. [DOI] [PubMed] [Google Scholar]
- 5.Lam K.K., Li W.H., Chiu S.Y., et al. The impact of cancer and its treatment on physical activity levels and quality of life among young Ho ng Kong Chinese cancer patients. Eur J Oncol Nurs. 2016;21:83–89. doi: 10.1016/j.ejon.2016.01.007. [DOI] [PubMed] [Google Scholar]
- 6.Rodin G., Lo C., Rydall A., et al. Managing cancer and living meaningfully (CALM): a randomized controlled trial of a psychological inte rvention for patients with advanced cancer. J Clin Oncol. 2018;36(23):2422–2432. doi: 10.1200/JCO.2017.77.1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Neel C., Lo C., Rydall A., et al. Determinants of death anxiety in patients with advanced cancer. BMJ Support Palliat Care. 2015;5(4):373–380. doi: 10.1136/bmjspcare-2012-000420. [DOI] [PubMed] [Google Scholar]
- 8.Beydag K.D. Factors affecting the death anxiety levels of relatives of cancer patients undergoing treatment. Asian Pac J Cancer Prev APJCP. 2012;13(5):2405–2408. doi: 10.7314/apjcp.2012.13.5.2405. [DOI] [PubMed] [Google Scholar]
- 9.Verin R.E., Menzies R.E., Menzies R.G. OCD, death anxiety, and attachment: what's love got to do with it? Behav Cognit Psychother. 2022;50(2):131–141. doi: 10.1017/S135246582100045X. [DOI] [PubMed] [Google Scholar]
- 10.Osborne J.W. An existential perspective on death anxiety, retirement, and related research problems. Can J Aging. 2017;36(2):246–255. doi: 10.1017/S0714980816000465. [DOI] [PubMed] [Google Scholar]
- 11.Grossman C.H., Brooker J., Michael N., et al. Death anxiety interventions in patients with advanced cancer: a systematic review. Palliat Med. 2018;32(1):172–184. doi: 10.1177/0269216317722123. [DOI] [PubMed] [Google Scholar]
- 12.Lo C., Hales S., Zimmermann C., et al. Measuring death-related anxiety in advanced cancer: preliminary psychometrics of the Death and Dying Distress Scale. J Pediatr Hematol Oncol. 2011;33(suppl 2):S140–S145. doi: 10.1097/MPH.0b013e318230e1fd. [DOI] [PubMed] [Google Scholar]
- 13.Tong E., Deckert A., Gani N., et al. The meaning of self-reported death anxiety in advanced cancer. Palliat Med. 2016;30(8):772–779. doi: 10.1177/0269216316628780. [DOI] [PubMed] [Google Scholar]
- 14.Eggen A.C., Reyners A.K.L., Shen G., et al. Death anxiety in patients with metastatic non-small cell lung cancer with and without brain metastase s. J Pain Symptom Manag. 2020;60(2):422–429. doi: 10.1016/j.jpainsymman.2020.02.023. [DOI] [PubMed] [Google Scholar]
- 15.Taghiabadi M., Kavosi A., Mirhafez S.R., et al. The association between death anxiety with spiritual experiences and life satisfaction in elderly peo ple. Electron Physician. 2017;9(3):3980–3985. doi: 10.19082/3980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Sherman D.W., Norman R., McSherry C.B. A comparison of death anxiety and quality of life of patients with advanced cancer or AIDS and their family caregivers. J Assoc Nurses AIDS Care. 2010;21(2):99–112. doi: 10.1016/j.jana.2009.07.007. [DOI] [PubMed] [Google Scholar]
- 17.Soleimani M.A., Lehto R.H., Negarandeh R., et al. Relationships between death anxiety and quality of life in Iranian patients with cancer. Asia Pac J Oncol Nurs. 2016;3(2):183–191. doi: 10.4103/2347-5625.182935. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Brown A.J., Shen M.J., Ramondetta L.M., et al. Does death anxiety affect end-of-life care discussions? Int J Gynecol Cancer. 2014;24(8):1521–1526. doi: 10.1097/IGC.0000000000000250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Kelly B., Burnett P., Pelusi D., et al. Factors associated with the wish to hasten death: a study of patients with terminal illness. Psychol Med. 2003;33(1):75–81. doi: 10.1017/s0033291702006827. [DOI] [PubMed] [Google Scholar]
- 20.Varelius J. Medical expertise, existential suffering and ending life. J Med Ethics. 2014;40(2):104–107. doi: 10.1136/medethics-2012-100812. [DOI] [PubMed] [Google Scholar]
- 21.Lodhi M.K., Cheema U.I., Stifter J., et al. Death anxiety in hospitalized end-of-life patients as captured from a structured electronic health re cord: differences by patient and nurse characteristics. Res Gerontol Nurs. 2014;7(5):224–234. doi: 10.3928/19404921-20140818-01. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Grumann M.M., Spiegel D. Living in the face of death: interviews with 12 terminally ill women on home hospice care. Palliat Support Care. 2003;1(1):23–32. doi: 10.1017/s1478951503030116. [DOI] [PubMed] [Google Scholar]
- 23.Soleimani M.A., Bahrami N., Allen K.A., et al. Death anxiety in patients with cancer: a systematic review and meta-analysis. Eur J Oncol Nurs. 2020;48 doi: 10.1016/j.ejon.2020.101803. [DOI] [PubMed] [Google Scholar]
- 24.Tang P.L., Chiou C.P., Lin H.S., et al. Correlates of death anxiety among Taiwanese cancer patients. Cancer Nurs. 2011;34(4):286–292. doi: 10.1097/NCC.0b013e31820254c6. [DOI] [PubMed] [Google Scholar]
- 25.Peters L., Cant R., Payne S., et al. How death anxiety impacts nurses' caring for patients at the end of life: a review of literature. Open Nurs J. 2013;7:14–21. doi: 10.2174/1874434601307010014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Cella D.F., Tross S. Death anxiety in cancer survival: a preliminary cross-validation study. J Pers Assess. 1987;51(3):451–461. doi: 10.1207/s15327752jpa5103_12. [DOI] [PubMed] [Google Scholar]
- 27.Gonen G., Kaymak S.U., Cankurtaran E.S., et al. The factors contributing to death anxiety in cancer patients. J Psychosoc Oncol. 2012;30(3):347–358. doi: 10.1080/07347332.2012.664260. [DOI] [PubMed] [Google Scholar]
- 28.Wang Yang Z.J.L.M. Death anxiety of patients with colorectal cancer. J Nurs Care. 2014;21(5):70–72. [Google Scholar]
- 29.Burke B.L., Martens A., Faucher E.H. Two decades of terror management theory: a meta-analysis of mortality salience research. Pers Soc Psychol Rev. 2010;14(2):155–195. doi: 10.1177/1088868309352321. [DOI] [PubMed] [Google Scholar]
- 30.Zhang J., Peng J., Gao P., et al. Relationship between meaning in life and death anxiety in the elderly: self-esteem as a mediator. BMC Geriatr. 2019;19(1):308. doi: 10.1186/s12877-019-1316-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Liu X., Liu Z., Cheng Q., et al. Effects of meaning in life and individual characteristics on dignity in patients with advanced cancer in China: a cross-sectional study. Support Care Cancer. 2021;29(5):2319–2326. doi: 10.1007/s00520-020-05732-2. [DOI] [PubMed] [Google Scholar]
- 32.Gravier A.L., Shamieh O., Paiva C.E., et al. Meaning in life in patients with advanced cancer: a multinational study. Support Care Cancer. 2020;28(8):3927–3934. doi: 10.1007/s00520-019-05239-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Uslu-Sahan F., Terzioglu F., Hopelessness Koc G. Death anxiety, and social support of hospitalized patients with gynecologic cancer and their caregivers. Cancer Nurs. 2019;42(5):373–380. doi: 10.1097/NCC.0000000000000622. [DOI] [PubMed] [Google Scholar]
- 34.Heru A.M., Drury L. Overcoming barriers in working with families. Acad Psychiatr. 2006;30(5):379–384. doi: 10.1176/appi.ap.30.5.379. [DOI] [PubMed] [Google Scholar]
- 35.Lim J.W. Communication, coping, and quality of life of breast cancer survivors and family/friend dyads: a pilo t study of Chinese-Americans and Korean-Americans. Psycho Oncol. 2014;23(11):1243–1251. doi: 10.1002/pon.3532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Mikulincer M., Florian V., Hirschberger G. The existential function of close relationships: introducing death into the science of love. Pers Soc Psychol Rev. 2003;7(1):20–40. doi: 10.1207/S15327957PSPR0701_2. [DOI] [PubMed] [Google Scholar]
- 37.Rongshou Z., Xiuying G., Xueting L., et al. Analysis on the trend of cancer incidence and age change in cancer registry areas of China,2000 to 2014. Chin J Prev Med. 2018;52(6):593–600. doi: 10.3760/cma.j.issn.0253-9624.2018.06.007. [DOI] [PubMed] [Google Scholar]
- 38.Hong Y., Yuhan L., Youhui G., et al. Death anxiety among advanced cancer patients: a cross-sectional survey. Support Care Cancer. 2022;30(4):3531–3539. doi: 10.1007/s00520-022-06795-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Royal K.D., Elahi F. Psychometric properties of the Death Anxiety Scale (DAS) among terminally ill cancer patients. J Psychosoc Oncol. 2011;29(4):359–371. [PubMed] [Google Scholar]
- 40.Shujuan C. Anhui Medical University; 2017. The Cross-Cultural Adaptation and Application of Death and Dying Distress Scale for Advanced Cancer Patients [D] [Google Scholar]
- 41.Wu M. Chongqing University Press; 2010. Practice of Questionnaire Statistical Analysis: SPSS Operation and application[M] [Google Scholar]
- 42.Willems A., Kudrashou A.F., Theunissen M., et al. Measuring pain in oncology outpatients: Numeric Rating Scale versus acceptable/non acceptable pain. A prospective single center study. Pain Pract. 2021;21(8):871–876. doi: 10.1111/papr.13053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Mehta A., Chai E., Berglund K., et al. Using admission Karnofsky performance status as a guide for palliative care discharge needs. J Palliat Med. 2021;24(6):910–913. doi: 10.1089/jpm.2020.0543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Smilkstein G., Ashworth C., Montano D. Validity and reliability of the family APGAR as a test of family function. J Fam Pract. 1982;15(2):303–311. [PubMed] [Google Scholar]
- 45.Li C., Lu H., Qin W., et al. Resilience and its predictors among Chinese liver cancer patients undergoing transarterial chemoembolization. Cancer Nurs. 2019;42(5):E1–E9. doi: 10.1097/NCC.0000000000000640. [DOI] [PubMed] [Google Scholar]
- 46.Yongsheng W. Guangxi Medical University; 2009. Preliminary Preparation and Evaluation of Purpose in Life Test for Advanced Cancer patients[D] [Google Scholar]
- 47.Vehling S., Malfitano C., Shnall J., et al. A concept map of death-related anxieties in patients with advanced cancer. BMJ Support Palliat Care. 2017;7(4):427–434. doi: 10.1136/bmjspcare-2016-001287. [DOI] [PubMed] [Google Scholar]
- 48.Ma G. Common pitfalls in reporting the use of SPSS software. Med Princ Pract. 2015;24(3):300. doi: 10.1159/000381953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.David W., Jr., Hosmer, Stanley Lemeshow, Sturdivant R.X. 3rd ed. John Wiley & Sons; Hoboken, New Jersey: 2013. Applied Logistic Regression. [Google Scholar]
- 50.Routledge C., Juhl J. When death thoughts lead to death fears: mortality salience increases death anxiety for individuals who lack meaning in life. Cognit Emot. 2010;24(5):848–854. [Google Scholar]
- 51.Chang B., Cheng J., Fang J., et al. The indirect effect of death anxiety on experienced meaning in life via search for meaning and prosocial behavior. Front Psychol. 2021;12 doi: 10.3389/fpsyg.2021.673460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Zhang Kaijin, Jiang Li, Huang Xin, et al. Research on impact factors of maliqnant tumor's direct economic burden ano medical security system. Chinese General Practice. 2010;13(36):4115–4118. [Google Scholar]
- 53.Wang Y.B.F.Y., Zhen-hua Study on the economic burden and health insurance policy of tumor diseases. Health Economics Research. 2018;(4):14–16. [Google Scholar]
- 54.Cleeland C.S., Zhao F., Chang V.T., et al. The symptom burden of cancer: evidence for a core set of cancer-related and treatment-related symptom s from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer. 2013;119(24):4333–4340. doi: 10.1002/cncr.28376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Vehling S., Kissane D.W., Lo C., et al. The association of demoralization with mental disorders and suicidal ideation in patients with cancer. Cancer. 2017;123(17):3394–3401. doi: 10.1002/cncr.30749. [DOI] [PubMed] [Google Scholar]
- 56.Mehnert A., Vehling S., H Cker A., et al. Demoralization and depression in patients with advanced cancer: validation of the German version of the demoralization scale. J Pain Symptom Manag. 2011;42(5):768–776. doi: 10.1016/j.jpainsymman.2011.02.013. [DOI] [PubMed] [Google Scholar]
- 57.Rodin G., Lo C., Mikulincer M., et al. Pathways to distress: the multiple determinants of depression, hopelessness, and the desire for hastened death in metastatic cancer patients. Soc Sci Med. 2009;68(3):562–569. doi: 10.1016/j.socscimed.2008.10.037. [DOI] [PubMed] [Google Scholar]
- 58.An E., Lo C., Hales S., et al. Demoralization and death anxiety in advanced cancer. Psycho Oncol. 2018;27(11):2566–2572. doi: 10.1002/pon.4843. [DOI] [PubMed] [Google Scholar]
- 59.Krause S., Rydall A., Hales S., et al. Initial validation of the Death and Dying Distress Scale for the assessment of death anxiety in patients with advanced cancer. J Pain Symptom Manag. 2015;49(1):126–134. doi: 10.1016/j.jpainsymman.2014.04.012. [DOI] [PubMed] [Google Scholar]
- 60.Simmons L.A. Self-perceived burden in cancer patients: validation of the Self-perceived Burden Scale. Cancer Nurs. 2007;30(5):405–411. doi: 10.1097/01.NCC.0000290816.37442.af. [DOI] [PubMed] [Google Scholar]
- 61.Robinson S., Kissane D.W., Brooker J., et al. A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: a decade of research. J Pain Symptom Manag. 2015;49(3):595–610. doi: 10.1016/j.jpainsymman.2014.07.008. [DOI] [PubMed] [Google Scholar]
- 62.Bovero A., Sedghi N.A., Opezzo M., et al. Dignity-related existential distress in end-of-life cancer patients: prevalence, underlying factors, and associated coping strategies. Psycho Oncol. 2018;27(11):2631–2637. doi: 10.1002/pon.4884. [DOI] [PubMed] [Google Scholar]
- 63.Lichtenthal W.G., Nilsson M., Zhang B., et al. Do rates of mental disorders and existential distress among advanced stage cancer patients increase a s death approaches? Psychooncology. 2009;18(1):50–61. doi: 10.1002/pon.1371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Ando M., Morita T., O'Connor S.J. Primary concerns of advanced cancer patients identified through the structured life review process: a qualitative study using a text mining technique. Palliat Support Care. 2007;5(3):265–271. doi: 10.1017/s1478951507000430. [DOI] [PubMed] [Google Scholar]
- 65.Drolet J.L. Transcending death during early adulthood: symbolic immortality, death anxiety, and purpose in life. J Clin Psychol. 1990;46(2):148–160. doi: 10.1002/1097-4679(199003)46:2<148::aid-jclp2270460205>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
- 66.Hong-pu X.L.C.Q. Research progress for remote medical treatment of basic medical lnsurance in China. Chinese Hospital Management. 2018;38(6):25–27. [Google Scholar]
- 67.Huimin X., Huizhen C., Jianwei Z. Correlation between coping styles,family relationship and self-esteem amono patients with breast cancer. Chin J Nurs. 2011;46(9):901–903. [Google Scholar]
- 68.Philipp R., Mehnert-Theuerkauf A., Koranyi S., et al. The role of attachment avoidance: a longitudinal mediation model predicting existential distress in patients with advanced cancer. Psycho Oncol. 2021;30(7):1059–1067. doi: 10.1002/pon.5640. [DOI] [PubMed] [Google Scholar]

